Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Digestive Diseases and Sciences
|
April 20, 2018
GI Bleeding Risk of DOACs Versus Warfarin: Is Newer Better?
Linda A Feagins, Rick A Weideman
International Urology and Nephrology
|
August 26, 2010
Thiazides diuretics in the treatment of nephrolithiasis: are we using them in an evidence-based fashion?
Rebecca Vigen, Rick A Weideman, Robert F Reilly
American Journal of Physical Medicine & Rehabilitation
|
June 14, 2021
Phosphodiesterase 5 Inhibitor Use in Patients Undergoing Decompression Surgery for Lumbar Spinal Stenosis
Tri Pham, Adam Butler, Rick A Weideman, et al.
Intestinal Research
|
April 8, 2020
Safety of tumor necrosis factor inhibitor use in patients with concomitant malignancy
Hiep Phan, Rick A Weideman, Daisha J Cipher, et al.
The American Journal of Managed Care
|
October 25, 2002
COX-2-specific inhibitors: prescribing patterns in a large managed care health system and strategies to minimize costs
Rick A Weideman, Kevin C Kelly, Catherine L Kelley, et al.
Inflammatory Bowel Diseases
|
December 23, 2017
Factors Associated With Length of Stay in Veterans With Inflammatory Bowel Disease Hospitalized for an Acute Flare
Michael Kelso, Rick A Weideman, Daisha J Cipher, et al.
Journal of Pharmacy Practice
|
January 19, 2024
Risk of Urinary Infections in Veterans on Empagliflozin With Concurrent Catheter Use
Rachel A Hopper, Danni M McMahan, Kathryn A Jarvis, et al.
Journal of Pharmacy Practice
|
January 21, 2020
Evaluation of Vitamin B<sub>12</sub> Monitoring in Veterans With Type 2 Diabetes on Metformin Therapy
Haley A Runeberg, Ashley M Higbea, Rick A Weideman, et al.
Journal of Cardiovascular Translational Research
|
February 22, 2012
The clinical relevance of the clopidogrel-proton pump inhibitor interaction
Atif Mohammad, Emmanouil S Brilakis, Rick A Weideman, et al.
Therapeutic Advances in Neurological Disorders
|
July 11, 2020
Diclofenac reduces the risk of Alzheimer's disease: a pilot analysis of NSAIDs in two US veteran populations
Olaf Stuve, Rick A Weideman, Danni M McMahan, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Digestive Diseases and Sciences
|
April 20, 2018
GI Bleeding Risk of DOACs Versus Warfarin: Is Newer Better?
Linda A Feagins, Rick A Weideman
International Urology and Nephrology
|
August 26, 2010
Thiazides diuretics in the treatment of nephrolithiasis: are we using them in an evidence-based fashion?
Rebecca Vigen, Rick A Weideman, Robert F Reilly
American Journal of Physical Medicine & Rehabilitation
|
June 14, 2021
Phosphodiesterase 5 Inhibitor Use in Patients Undergoing Decompression Surgery for Lumbar Spinal Stenosis
Tri Pham, Adam Butler, Rick A Weideman, et al.
Intestinal Research
|
April 8, 2020
Safety of tumor necrosis factor inhibitor use in patients with concomitant malignancy
Hiep Phan, Rick A Weideman, Daisha J Cipher, et al.
The American Journal of Managed Care
|
October 25, 2002
COX-2-specific inhibitors: prescribing patterns in a large managed care health system and strategies to minimize costs
Rick A Weideman, Kevin C Kelly, Catherine L Kelley, et al.
Inflammatory Bowel Diseases
|
December 23, 2017
Factors Associated With Length of Stay in Veterans With Inflammatory Bowel Disease Hospitalized for an Acute Flare
Michael Kelso, Rick A Weideman, Daisha J Cipher, et al.
Journal of Pharmacy Practice
|
January 19, 2024
Risk of Urinary Infections in Veterans on Empagliflozin With Concurrent Catheter Use
Rachel A Hopper, Danni M McMahan, Kathryn A Jarvis, et al.
Journal of Pharmacy Practice
|
January 21, 2020
Evaluation of Vitamin B<sub>12</sub> Monitoring in Veterans With Type 2 Diabetes on Metformin Therapy
Haley A Runeberg, Ashley M Higbea, Rick A Weideman, et al.
Journal of Cardiovascular Translational Research
|
February 22, 2012
The clinical relevance of the clopidogrel-proton pump inhibitor interaction
Atif Mohammad, Emmanouil S Brilakis, Rick A Weideman, et al.
Therapeutic Advances in Neurological Disorders
|
July 11, 2020
Diclofenac reduces the risk of Alzheimer's disease: a pilot analysis of NSAIDs in two US veteran populations
Olaf Stuve, Rick A Weideman, Danni M McMahan, et al.
Page
of 3